Literature DB >> 12221404

The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis.

Przemysław Palka1, Graeme Macdonald, Aleksandra Lange, Darryl J Burstow.   

Abstract

Although cardiac dysfunction in hereditary hemochromatosis (HHC) can be evaluated by conventional echocardiography, findings are often not specific. To test the hypothesis that the assessment of (1) conventional Doppler left ventricular filling indexes and (2) intrinsic elastic properties of the myocardium by Doppler tissue echocardiography can both enhance the accuracy of echocardiographic diagnosis of cardiac involvement in HHC, a group of 18 patients with HHC (mean age 50 +/- 17 years) and 22 age-matched healthy subjects were studied. The following indexes were characteristic for HHC: (1) the duration of atrial reversal measured from pulmonary venous flow (ms) was longer (118 +/- 20 vs 90 +/- 16; P <.001); (2) systolic lateral mitral, early-diastolic medial mitral, and early-diastolic lateral tricuspid annular velocities were reduced by 23%, 31%, and 13%, respectively; (3) late-diastolic mean myocardial velocity and myocardial velocity gradient (MVG) were also reduced by 22% and 34%, respectively. Late-isovolumic relaxation (late-IVR) MVG (s(-1)) was positive in HHC as opposed to negative in healthy subjects (1.72 +/- 0.85 vs -0.89 +/- 1.15; P <.001) indicating impaired early-diastolic subepicardial relaxation in HHC. The assessment of atrial reversal flow duration, the difference in duration between A-wave and atrial reversal flow, and the presence of positive late IVR-MVG findings were the most accurate variables to differentiate patients with HHC from healthy subjects (80%, 67%, 94% sensitivity and 90%, 95%, 86% specificity, respectively).

Entities:  

Mesh:

Year:  2002        PMID: 12221404     DOI: 10.1067/mje.2002.118032

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Authors:  Yukitaka Shizukuda; Kevin P Smith; Dorothy J Tripodi; Ross Arena; Yu-Ying Yau; Charles D Bolan; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

2.  Improvements in cardiac function detected using echocardiography in patients with hereditary haemochromatosis.

Authors:  Danielle Byrne; John Patrick Walsh; Caroline Daly; Susan McKiernan; Suzanne Norris; Ross T Murphy; Gerard King
Journal:  Ir J Med Sci       Date:  2019-05-20       Impact factor: 1.568

Review 3.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

Review 4.  Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging.

Authors:  M Jason Zimmerman; Douglas R Rosing; Yukitaka Shizukuda
Journal:  J Echocardiogr       Date:  2021-03-26

5.  Usefulness of pulsed wave tissue doppler imaging in assessment of left ventricular functions in children with beta-thalassemia major.

Authors:  Ahmed Mahmoud Abdelmoktader; Hany Younan Azer
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967

6.  Left ventricular long-axis function in treated haemochromatosis.

Authors:  Einar Skulstad Davidsen; Tor Hervig; Per Omvik; Eva Gerdts
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-13       Impact factor: 2.357

Review 7.  Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.

Authors:  Gavin Y Oudit; Maria G Trivieri; Neelam Khaper; Peter P Liu; Peter H Backx
Journal:  J Mol Med (Berl)       Date:  2006-04-08       Impact factor: 4.599

Review 8.  Hereditary Hemochromatosis: A Cardiac Perspective.

Authors:  Pranay K Joshi; Saawan C Patel; Devarashetty Shreya; Diana I Zamora; Gautami S Patel; Idan Grossmann; Kevin Rodriguez; Mridul Soni; Ibrahim Sange
Journal:  Cureus       Date:  2021-11-29

9.  Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis.

Authors:  Abitha Sukumaran; JuOae Chang; Murui Han; Shrutika Mintri; Ban-An Khaw; Jonghan Kim
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

10.  Management of cardiac hemochromatosis.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-06-30       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.